Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present)

Published:2021-05-13 Issue:10 Volume:31 Page:867-876
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Nocentini Alessio¹^ORCID,Capasso Clemente²^ORCID,Supuran Claudiu T.¹^ORCID

Affiliation:

1. Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche E Nutraceutiche, Università Degli Studi Di Firenze, Sesto Fiorentino (Florence), Italy

2. Department of Biology, Agriculture and Food Sciences, CNR, Institute of Biosciences and Bioresources, Napoli, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1923694

Reference100 articles.

1. 5′-Nucleotidases and their new roles in NAD+ and phosphate metabolism

2. Ecto-5’-nucleotidase: Structure function relationships

3. Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death

4. Interrelations between substrate cycles and de novo synthesis of pyrimidine deoxyribonucleoside triphosphates in 3T6 cells.

5. CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic pathways and their clinical use in the treatment of acute myeloid leukemia;Purinergic Signalling;2024-03-06

2. CD73 (5′-Ectonucleotidase);Metalloenzymes;2024

3. Chronobiologically Targeted Anticancer Strategy: Synergistic Inhibition of CD39 and CD73 with Adenosine Receptor Agonists;Interdisciplinary Cancer Research;2024

4. Tumor Microenvironment Responsive CD8⁺ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer;Advanced Science;2023-10-22

5. Anti-inflammatory potency of novel ecto-5′-nucleotidase/CD73 inhibitors in astrocyte culture model of neuroinflammation;European Journal of Pharmacology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3